Biora Therapeutics, Inc. (BIOR) Analyst Estimates Annual - Discounting Cash Flows
BIOR
Biora Therapeutics, Inc.
BIOR (OTC)
Period Ending: 2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2020
12-30
Number of Analysts 1 1 1 1 1 1 1 1 1
Estimated Revenue
Low 20.6 6.1 5.5 5 0.965 0.86 0.001 0.051 0.17
Average 20.6 6.1 5.5 5 1.1 0.86 0.3 25.44 84.95
High 20.6 6.1 5.5 5 1.23 0.86 0.599 50.82 169.7
Estimated EBITDA
Low -20.36 -6.03 -5.43 -4.94 -1.22 -0.85 -0.592 -50.22 -167.7
Average -20.36 -6.03 -5.43 -4.94 -1.09 -0.85 -0.296 -25.13 -83.94
High -20.36 -6.03 -5.43 -4.94 -0.954 -0.85 -0.001 -0.05 -0.168
Estimated EBIT
Low -20.49 -6.07 -5.47 -4.97 -1.23 -0.855 -0.596 -50.54 -168.8
Average -20.49 -6.07 -5.47 -4.97 -1.09 -0.855 -0.298 -25.3 -84.48
High -20.49 -6.07 -5.47 -4.97 -0.96 -0.855 -0.001 -0.051 -0.169
Estimated Net Income
Low -2 -2.93 -5.24 -10.42 -18.14 -52.33 -195.9 -1,726 -5,304
Average -2 -2.93 -5.24 -8.09 -13.92 -52.33 -63.59 -751.2 -2,309
High -2 -2.93 -5.24 -5.75 -9.71 -52.33 25.35 223.4 686.7
Estimated SGA Expenses
Low 39,195 11,606 10,465 9,513 1,837 1,636 1.14 96.69 322.9
Average 39,195 11,606 10,465 9,513 2,093 1,636 570.8 48,395 161,626
High 39,195 11,606 10,465 9,513 2,349 1,636 1,140 96,694 322,930
Estimated EPS
Low -1.27 -1.86 -3.32 -6.61 -11.5 -33.17 -124.2 -1,094 -3,363
Average -1.27 -1.86 -3.32 -5.13 -8.83 -33.17 -54.05 -476.2 -1,464
High -1.27 -1.86 -3.32 -3.65 -6.15 -33.17 16.07 141.6 435.3
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program